US Stock MarketDetailed Quotes

DNMR Danimer Scientific

Watchlist
  • 1.180
  • -0.020-1.67%
15min DelayClose Feb 14 16:00 ET
3.56MMarket Cap-0.03P/E (TTM)

About Danimer Scientific Company

Danimer Scientific, Inc. operates as a next generation bioplastics company. It focuses on the development and production of biodegradable materials. The firm sells its products under the brand name Nodax. Its applications for biopolymers include additives, aqueous coatings, fibers, filaments, films, and injection-molded articles. The company was founded on January 13, 2014 and is headquartered in Bainbridge, GA.

Company Profile

SymbolDNMR
Company NameDanimer Scientific
Listing DateMay 28, 2020
Founded2014
CEOMr. Richard N. Altice
MarketPink Market
Employees257
Fiscal Year Ends12-31
Address140 Industrial Boulevard
CityBainbridge
ProvinceGeorgia
CountryUnited States of America
Zip Code39817
Phone1-229-243-7075

Company Executives

  • Name
  • Position
  • Salary
  • Richard N. Altice
  • Director and Interim Chief Executive Officer
  • --
  • Scott Tuten
  • Chief Marketing Officer and Chief Sustainability Officer
  • 334.12K
  • Michael Eric Smith
  • Chief Operating Officer
  • --
  • Phillip Van Trump
  • Chief Science Officer and Chief Technology Officer
  • --
  • Michael A. Hajost
  • Chief Financial Officer and Principal Accounting Officer
  • 822.61K
  • Richard J. Hendrix
  • Interim Executive Chairman of the Board
  • 105.00K
  • Stephen E. Croskrey
  • Director
  • 3.36M
  • Dr. David J. Moody, PhD
  • Director
  • --
  • Gregory William Hunt
  • Independent Director
  • 120.00K
  • Allison M. Leopold Tilley
  • Independent Director
  • 100.00K
  • Stuart W. Pratt
  • Independent Director
  • 116.00K
  • Dr. Isao Noda
  • Independent Director
  • 100.00K
  • Philip Gregory Calhoun
  • Independent Director
  • 100.00K
  • John P. Amboian
  • Lead Independent Director
  • 130.00K

Trending Stocks

Discussing
Big Tech’s earnings season in full swing! Nvidia is the only one left
On Thursday, $Amazon (AMZN.US)$ stock fell after the firm reported Q4 adjusted earnings of $1.86/share, vs estimates of $1.50/share, on reve Show More